Citigroup Inc Dario Health Corp. Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$3.74 - $7.09 $501 - $950	-134 Reduced 45.12%	163 $1,000
Q2 2022 Aug 10, 2022	SELL	$4.33 - $7.45 $1,931 - $3,322	-446 Reduced 60.03%	297 $2,000
Q1 2022 May 12, 2022	SELL	$5.84 - $13.61 $162,416 - $378,507	-27,811 Reduced 97.4%	743 $4,000
Q4 2021 Feb 10, 2022	BUY	$12.52 - $19.02 $336,324 - $510,934	26,863 Added 1588.59%	28,554 $370,000
Q3 2021 Nov 10, 2021	BUY	$10.47 - $20.87 $17,704 - $35,291	1,691 New	1,691 $23,000

7.99M

104K

5.6K

Ticker DRIO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 23,295,000
Market Cap $17.2M
Description
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.